Trial Nation contributes substantially to Denmark’s position as the leading public-private ecosystem for clinical trials in Europe – to the benefit of patients, research and the economy.

  • We create the foundation for expansion, and we maintain a position for Denmark among the top three countries in Europe, measured as number of clinical trials per million inhabitants.
  • We strengthen frameworks and conditions to attract significantly more clinical trials at the highest international level.
  • We lead in state-of-the-art methods and technologies in set-up and execution of clinical trials.


We pave the way to a future where:

Patients enjoy stronger sustainable health driven by fast access to cutting-edge medicine and medical technology.

Healthcare professionals save more lives and promote stronger health by always having state-of-the-art medical research and the latest discoveries right at their hand.

Clinical research create a better health and wealth for Denmark.


Trial Nation is the result of strong and continuous governmental support of the Danish life science sector. The organisation is supported by the Ministry of Industry, Business and Financial Affairs and the five Danish Regions.

In 2014 the precursor to Trial Nation, NEXT Partnership, was established with political and industrial endorsement. The Innovation Fund Denmark contributed with a large investment.

In late 2018 Trial Nation was founded as a merge between NEXT Partnership (Funded by the Innovation Fund Denmark and members in the partnership) and Clinical Trials Office Denmark (Funded by the five Danish Regions).

In 2019 Trial Nation became the first Danish Associated Partner to an IMI project. The project is the flagship project Health Outcomes Observatories (H2O).

In 2021 Trial Nation was tasked with overseeing the establishment of the first real-time updated overview of recruiting clinical trials, allowing patients and healthcare professionals to find clinical trials that may be suitable for them. Launch is expected 2023.

In 2022 Danish Patients and Organisation of Danish Medical Societies changed their status from observatory members to full members on the board of Trial Nation.